<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122564">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01728272</url>
  </required_header>
  <id_info>
    <org_study_id>KUH5101066</org_study_id>
    <nct_id>NCT01728272</nct_id>
  </id_info>
  <brief_title>Influence of CPB and Mini CPB to the Absorption of the Metoprolol</brief_title>
  <acronym>Minimeto</acronym>
  <official_title>Influence of CPB and Mini CPB to the Absorption of the Metoprolol After CABG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <authority>Finland: Ministry of Social Affairs and Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Influence of perfusion, miniperfusion and off pump coronary artery bypass grafting to the
      absorbtion of metoprolol postoperatively, hypothesis in that miniperfusion and off pump
      surgery does not decrease absorbtion of the metoprolol compared to conventional pefusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Influence of perfusion, miniperfusion and off pump coronary artery bypass grafting to the
      absorbtion of metoprolol postoperatively, hypothesis in that miniperfusion and off pump
      surgery does not decrease absorbtion of the metoprolol compared to conventional pefusion.

      Blood samples for concentration of metoprolol are taken preoperaively, 1. and 3. day after
      operation, before and 10 times after intake of 50 mg metoprolol.

      Sudy is randomized into 3 groups: 1. Miniperfusion n.15 2. Perfusion n.15 3. offpump n.15
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>absorbtion of the metoprolol</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>absorbtion of the metoprolol, blood samples are taken centrifuged, frozed and analyzed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>atrial fibrillation</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>is there correlation of incidence of the postopeative AF and absorbtion of the metoprolol</description>
  </secondary_outcome>
  <other_outcome>
    <measure>recovery from rocedure</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>How does gereral recovery correlate between randomized groups</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Drug Absorption</condition>
  <arm_group>
    <arm_group_label>blood concentration of metoprolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>how does off-pump miniperfusion and perfusion CABG influence the absorption of metoprolol after CABG</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>blood concentration of metoprolol</intervention_name>
    <description>measure blood concentration of metoprolol</description>
    <arm_group_label>blood concentration of metoprolol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: elective CABG patient -

        Exclusion Criteria: contraindication to metoprolol

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>70100</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Maaroos, MD</last_name>
      <phone>358400218801</phone>
      <email>martin.maaroos@kuh.fi</email>
    </contact>
    <investigator>
      <last_name>Martin Maaroos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>November 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metoprolol, atrial fibrillation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Metoprolol</mesh_term>
    <mesh_term>Metoprolol succinate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
